Global Positive Airway Pressure Devices Market Overview:
Positive Airway Pressure Devices are used for common treatment for obstructive sleep apnea. These devices are used to keep the airways open while sleeping and control the output pressure by keeping the airflow pressure unbroken. The Positive Airway Pressure Devices market has high growth prospects due to the growing awareness of sleep apnea and related comorbid conditions such as obesity and high blood pressure. As per the Centre for Disease Control and Prevention, it is estimated that over 340 million people suffer from sleeping apnea. Additionally, technological advancements such as improved mask design and oral appliances contribute to market expansion. The major companies are adding more innovative techniques in Asia-Pacific countries as these countries are focused on the fastest-growing verticals for sleep apnea medication. According to AMA, the Global Positive Airway Pressure Devices market is expected to see growth rate of 8.6% and may see market size of USD3974.3 Million by 2024.
- Rising Prevalence of Sleeping Apnea
- Growing Geriatric Population Leads to Boost the Market
- Upsurge Demand for Mental Alertness and Improves Mood
- Increasing Demand from Asia-Pacific Regions
- Value-Oriented Customers
- High Cost Associated with CPAP Machines
- Long Waiting Periods and Complex Referral Pathways
- Technological Advancements in Sleeping Apnea Devices Such are CPAP, BiPAP and Others
- Increasing Awareness among Citizens on Obstructive Sleeping Apnea and its Treatments
- Adverse Impact Due to High Health Expenditure
- Absence of Patients Compliance Hamper the Market Growth
In the Positive Airway Pressure Devices market, it has been observed that most of the manufacturing companies are providing innovative portable travel-friendly CPAP devices and mandibular maxillomandibular advancement surgery. They rely on strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation and sourcing strategies to enhance their market share.
Some of the key players profiled in the report are Koninklijke Philips N.V. (Philips Respironics) (Netherlands), Curative Medical (United States), ResMed (United States), Fisher and Paykel Healthcare Limited (New Zealand), Drive DeVilbiss Healthcare Inc. (United States), Somnetics International, Inc (United States) and SomnoMed (United States). Additionally, following companies can also be profiled that are part of our coverage like Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada) and Panthera Dental (Canada.
“According to U.S. Food and Drug Administration (FDA), it classifies that the positive airway pressure (PAP) delivery system, moving it from Class III into Class II. PAP delivery systems continue to be for prescription use only. It also defines medical devices based on the risks associated with the device and by evaluating the amount of regulation that provides a reasonable assurance of the device’s safety and effectiveness. Class I devices generally pose the lowest risk to the patient, and Class III devices pose the highest risk.”
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Positive Airway Pressure Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Positive Airway Pressure Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Positive Airway Pressure Devices Manufacturers, Positive Airway Pressure Devices Suppliers, End-Use Market Participants of Different Segments of Positive Airway Pressure Devices, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.